QA: ALIMERA SCIENCES INC in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001267602_2018_ALIMERA_SCIENCES_INC.pdf

Logs

info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest'}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('stock_price')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001267602, ALIMERA SCIENCES INC

  xvar xval
0 AssetsCurrent 39,322,000
1 IntangibleAssetsNetIncludingGoodwill 18,664,000
2 PropertyPlantAndEquipmentNet 1,410,000
3 remainder_Assets 528,000
4 LiabilitiesCurrent 9,671,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 13,039,000
9 ResearchAndDevelopmentExpense 12,844,000
10 remainder_Expenses 32,223,000
11 remainder_Revenues 35,912,000
12 remainder_NetIncome 193,000
13 remainder_ComprehensiveNetIncome 451,000
  yvar yval
0 Assets 59,924,000
1 Liabilities 9,671,000
2 Expenses 58,106,000
3 Revenues 35,912,000
4 StockholdersEquity 50,253,000
5 NetIncome -22,001,000
6 ComprehensiveNetIncome -21,775,500
7 BaseVar 82,128,500
8 EconomicCapitalRatio 1.86

Edgar->Model Mapping

Feature Distribution

Change over Time